Cytek Biosciences (CTKB) Cost of Revenue (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Cost of Revenue came in at $22.9 million in Q1 2026, up 7.42% YoY from $21.3 million in Q1 2025, and down 21.79% on a QoQ basis from $29.3 million in Q4 2025.
Cytek Biosciences (CTKB) Cost of Revenue (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 7 years of Cost of Revenue data on file, last reported at $22.9 million in Q1 2026.
- Quarterly Cost of Revenue rose 7.42% year-over-year to $22.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.6 million (up 11.05% YoY) and the FY2025 annual result came in at $97.0 million, up 8.6% from the prior year.
- Cost of Revenue retreated to $22.9 million in Q1 2026, from $29.3 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $29.3 million in Q4 2025 to a low of $13.6 million in Q3 2022.
- A 5-year average of $20.9 million and a median of $21.5 million in 2023 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2023 — Cost of Revenue soared 52.93% — and 2024, when it fell 5.4%.
- Tracing CTKB's Cost of Revenue over 5 years: stood at $19.0 million in 2022, then jumped by 32.82% to $25.2 million in 2023, then fell by 5.4% to $23.8 million in 2024, then increased by 22.8% to $29.3 million in 2025, then declined by 21.79% to $22.9 million in 2026.
- The last three Cost of Revenue figures came in at $22.9 million (Q1 2026), $29.3 million (Q4 2025), and $24.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Cytek Biosciences | 615.21 Mn | 541.36 Mn | 28.34 Mn | 19.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.80 Mn |
| Jun 30, 2026 | 19.80 Mn |
| Mar 31, 2026 | 22.88 Mn |
| Mar 31, 2026 | 22.88 Mn |
| Dec 31, 2025 | 29.26 Mn |
| Dec 31, 2025 | 29.26 Mn |
| Sep 30, 2025 | 24.74 Mn |
| Sep 30, 2025 | 24.74 Mn |
| Jun 30, 2025 | 21.74 Mn |
| Jun 30, 2025 | 21.74 Mn |
| Mar 31, 2025 | 21.30 Mn |
| Mar 31, 2025 | 21.30 Mn |
| Dec 31, 2024 | 23.82 Mn |
| Dec 31, 2024 | 23.82 Mn |
| Sep 30, 2024 | 22.50 Mn |
| Sep 30, 2024 | 22.50 Mn |
| Jun 30, 2024 | 21.18 Mn |
| Jun 30, 2024 | 21.18 Mn |
| Mar 31, 2024 | 21.85 Mn |
| Mar 31, 2024 | 21.85 Mn |